UBS Group’s Octave Specialty Group OSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$919K Sell
147,197
-117,083
-44% -$610K ﹤0.01% 5807
2026
Q1
$1.23M Buy
264,280
+110,416
+72% +$632K ﹤0.01% 5387
2025
Q4
$1.2M Sell
153,864
-125,625
-45% -$1.07M ﹤0.01% 5422
2025
Q3
$2.33M Sell
279,489
-80,776
-22% -$682K ﹤0.01% 4808
2025
Q2
$2.56M Buy
360,265
+218,334
+154% +$1.63M ﹤0.01% 4561
2025
Q1
$1.24M Buy
141,931
+52,403
+59% +$552K ﹤0.01% 5089
2024
Q4
$1.13M Buy
89,528
+70,333
+366% +$848K ﹤0.01% 5207
2024
Q3
$215K Buy
19,195
+8,216
+75% +$96.1K ﹤0.01% 5819
2024
Q2
$141K Sell
10,979
-23,632
-68% -$360K ﹤0.01% 5921
2024
Q1
$541K Buy
34,611
+6,407
+23% +$101K ﹤0.01% 5137
2023
Q4
$465K Buy
28,204
+12,822
+83% +$178K ﹤0.01% 5168
2023
Q3
$186K Sell
15,382
-22,542
-59% -$303K ﹤0.01% 5412
2023
Q2
$540K Sell
37,924
-801,344
-95% -$11.7M ﹤0.01% 4755
2023
Q1
$13M Buy
839,268
+451,498
+116% +$7.31M ﹤0.01% 1703
2022
Q4
$6.76M Buy
387,770
+376,179
+3,245% +$5.59M ﹤0.01% 2220
2022
Q3
$148K Buy
11,591
+2,591
+29% +$34.5K ﹤0.01% 5364
2022
Q2
$102K Sell
9,000
-542,993
-98% -$5.16M ﹤0.01% 5416
2022
Q1
$5.74M Buy
551,993
+541,367
+5,095% +$7.34M ﹤0.01% 2405
2021
Q4
$170K Sell
10,626
-319
-3% -$5.01K ﹤0.01% 5836
2021
Q3
$157K Sell
10,945
-59,558
-84% -$850K ﹤0.01% 5507
2021
Q2
$1.1M Sell
70,503
-19,487
-22% -$313K ﹤0.01% 4098
2021
Q1
$1.51M Sell
89,990
-6,115
-6% -$99.9K ﹤0.01% 3846
2020
Q4
$1.48M Buy
96,105
+9,781
+11% +$144K ﹤0.01% 3675
2020
Q3
$1.1M Sell
86,324
-474,470
-85% -$6.11M ﹤0.01% 3566
2020
Q2
$8.03M Buy
560,794
+471,369
+527% +$6.89M ﹤0.01% 1687
2020
Q1
$1.1M Sell
89,425
-37,132
-29% -$712K ﹤0.01% 3265
2019
Q4
$2.73M Buy
126,557
+31,334
+33% +$643K ﹤0.01% 3225
2019
Q3
$1.86M Buy
95,223
+28,287
+42% +$520K ﹤0.01% 3354
2019
Q2
$1.13M Buy
66,936
+12,643
+23% +$216K ﹤0.01% 3657
2019
Q1
$984K Sell
54,293
-15,090
-22% -$288K ﹤0.01% 3607
2018
Q4
$1.2M Buy
69,383
+3,374
+5% +$61.9K ﹤0.01% 3508
2018
Q3
$1.35M Buy
66,009
+7,829
+13% +$163K ﹤0.01% 3566
2018
Q2
$1.16M Buy
58,180
+2,334
+4% +$43.1K ﹤0.01% 3652
2018
Q1
$876K Sell
55,846
-3,598
-6% -$55.6K ﹤0.01% 3822
2017
Q4
$949K Sell
59,444
-1,379
-2% -$21.2K ﹤0.01% 3830
2017
Q3
$1.05M Buy
60,823
+5,051
+9% +$93.3K ﹤0.01% 3668
2017
Q2
$968K Buy
55,772
+1,901
+4% +$33.8K ﹤0.01% 3640
2017
Q1
$1.02M Sell
53,871
-23,662
-31% -$498K ﹤0.01% 3518
2016
Q4
$1.75M Buy
77,533
+43,272
+126% +$945K ﹤0.01% 3039
2016
Q3
$630K Buy
34,261
+9,889
+41% +$177K ﹤0.01% 3755
2016
Q2
$401K Sell
24,372
-1,336
-5% -$21.4K ﹤0.01% 4056
2016
Q1
$407K Sell
25,708
-1,899
-7% -$27.5K ﹤0.01% 3930
2015
Q4
$388K Buy
27,607
+16,521
+149% +$254K ﹤0.01% 4149
2015
Q3
$161K Buy
11,086
+825
+8% +$13.4K ﹤0.01% 4811
2015
Q2
$170K Buy
10,261
+1,468
+17% +$34.7K ﹤0.01% 5009
2015
Q1
$212K Buy
8,793
+3,138
+55% +$79.8K ﹤0.01% 4834
2014
Q4
$139K Buy
+5,655
New +$132K ﹤0.01% 5360

Other funds holding OSG

UBS Group's OSG Position: Q2 2026 in Review

UBS Group reduced its Octave Specialty Group (OSG) stake by 44% in Q2 2026, selling an estimated $610K and leaving 147,197 shares worth $919K. The position accounts for ﹤0.01% of the portfolio, ranked #5807.

UBS Group first reported a position in OSG in Q4 2014 and has held it in 47 quarters since. The position peaked at $13M in Q1 2023. 148 funds tracked by Wall St. Rank hold OSG as of Q2 2026.

  • UBS Group held 147,197 shares of Octave Specialty Group worth $919K as of Q2 2026.
  • UBS Group sold 117,083 Octave Specialty Group shares in Q2 2026, an estimated $610K.
  • Octave Specialty Group made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #5807 holding.
  • UBS Group first reported a position in Octave Specialty Group in Q4 2014 and has held it in 47 quarters since.
  • UBS Group's Octave Specialty Group position peaked at $13M in Q1 2023.
  • 148 funds tracked by Wall St. Rank held Octave Specialty Group as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.